# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Fibrolamellar carcinoma

Hepatocellular carcinoma (fibrolamellar variant)
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-4 of 4 results.
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Status: Recruiting
Last Changed: Apr 13, 2020
First Received: Jan 30, 2020
Disease(s): Fibrolamellar Hepatocellular Carcinoma (FLC)
Intervention(s): DNAJB1-PRKACA peptide vaccine, Nivolumab, Ipilimumab
Locations: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Status: Not yet recruiting
Last Changed: May 08, 2020
First Received: May 08, 2020
Disease(s): Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Fibrolamellar Carcinoma
Intervention(s): Fluorouracil, Nivolumab, Recombinant Interferon Alpha 2b-like Protein
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Status: Recruiting
Last Changed: Apr 30, 2020
First Received: May 23, 2018
Disease(s): Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma, Hepatocellular Malignant Neoplasm, Not Otherwise Specified
Intervention(s): Carboplatin, Cisplatin, Doxorubicin, Etoposide, Fluorouracil, Gemcitabine, Irinotecan, Laboratory Biomarker Analysis, Oxaliplatin, Patient Observation, Sorafenib, Vincristine Sulfate
Locations: Children's Hospital of Alabama, Birmingham, Alabama, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Cardon Children's Medical Center, Mesa, Arizona, United States
Phoenix Childrens Hospital, Phoenix, Arizona, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
... and 170 other locations.
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Recruiting
Last Changed: May 19, 2020
First Received: Jun 10, 2014
Disease(s): Advanced Malignant Solid Neoplasm, Fibrolamellar Carcinoma, Metastatic Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Neuroendocrine Tumor, Recurrent Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm, Unresectable Solid Neoplasm
Intervention(s): Sapanisertib, Ziv-Aflibercept
Locations: M D Anderson Cancer Center, Houston, Texas, United States